Related Experiment Video
Updated: Aug 18, 2026

Surgical Models of Gastroesophageal Reflux with Mice
Published on: August 25, 2015
Gastroesophageal reflux and unexplained chronic respiratory disease in infants and children
A Malfroot1, Y Vandenplas, M Verlinden
1Department of Pediatrics, Academisch Kinderziekenhuis V.U.B., Belgium.
Insights
Gastroesophageal reflux (GER) was identified as a likely cause of severe chronic pulmonary disease in 63% of children. Treating GER led to respiratory symptom remission in most patients, highlighting the link between reflux and lung issues.
Area of Science:
- Pediatric Pulmonology
- Gastroenterology
Background:
- Severe chronic pulmonary disease in children can have multifactorial causes.
- Gastroesophageal reflux (GER) is a potential but often overlooked contributor to pediatric respiratory conditions.
Purpose of the Study:
- To investigate the prevalence of gastroesophageal reflux (GER) in children with severe chronic pulmonary disease.
- To assess the impact of antireflux treatment on respiratory symptoms in this patient group.
Main Methods:
- Utilized prolonged pH probe monitoring and gastroesophageal scintiscanning in 38 children (infants to 7 years) with severe chronic pulmonary disease.
- Discontinued all prior treatments before diagnostic testing.
- Administered antireflux medication (cisapride) to patients diagnosed with GER.
Main Results:
- Gastroesophageal reflux (GER) was detected in 24 out of 38 patients (63%).
- Antireflux treatment controlled GER in 22 of 24 patients (92%), confirmed by improved pH monitoring and/or scintiscanning.
- Eighteen of these 22 patients (82%) experienced remission of their pulmonary disease following GER treatment, compared to only 2 of 14 patients (14%) in the control group.
Conclusions:
- Gastroesophageal reflux (GER) is a probable cause of severe chronic pulmonary disease in a significant proportion (63%) of pediatric patients.
- Effective management of GER can lead to substantial improvement and remission of respiratory symptoms.
- Combining pH probe monitoring and gastroesophageal scintiscanning enhances diagnostic accuracy for GER in pediatric respiratory patients.
Abstract:
Thirty-eight children, aged from a few weeks to 7 years, with severe chronic pulmonary disease and without gastrointestinal symptoms, were investigated for gastroesophageal reflux (GER), using prolonged pH probe monitoring and gastroesophageal scintiscanning. All treatments were discontinued before testing. GER was found in 24 patients (63%) (group I) and it was not observed in 14 patients (group II). All patients of group I received antireflux treatment, consisting of cisapride; in 22 of 24 patients, GER was controlled, as indicated by improvement of either pH monitoring or scintiscanning, or both. Eighteen of these 22 (82%) had remission of their pulmonary disease, and only two patients of group II (14%) had spontaneous remission of the respiratory symptoms. We concluded that GER was probably the cause of the respiratory disease in 63% of our patients, since treatment of GER was followed by disappearance of the respiratory complaints in most of them. The combination of gastroesophageal scintiscanning and pH probe study improved the diagnostic accuracy.
Related Concept Videos
Breathing
Pulmonary Cycle: Exhalation
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Gastroesophageal Reflux Disease

